Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
7.05
-0.10
(-1.40%)
At close: February 28 at 4:25:36 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Marc M. P. de Garidel M.B.A. | CEO & Director | 793.97k | -- | 1958 |
| Mr. Didier Blondel | EVP, CFO & Board Secretary | -- | -- | 1964 |
| Mr. Didier Scherrer Ph.D. | Chief Scientific Officer | -- | -- | 1970 |
| Mr. Patrick Malloy | Senior Vice President of Investor Relations | -- | -- | -- |
| Ms. Ida Hatoum | Chief People & Compliance Officer | -- | -- | 1975 |
| Mr. Pierre Courteille M.B.A. | Chief Business Officer | -- | -- | 1969 |
| Mr. Jerome Denis Ph.D. | Executive Vice President of Process Development & Manufacturing | -- | -- | -- |
| Ms. Ana Sharma M.P.H. | VP & Global Head of Quality | -- | -- | -- |
| Hema Keshava | Senior Vice President of Finance | -- | -- | -- |
| Chris Rabbat Ph.D. | VP & Global Head of Medical Affairs | -- | -- | -- |
ABIVAX Société Anonyme
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 62
Description
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Corporate Governance
ABIVAX Société Anonyme’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 24, 2025 at 3:00 PM UTC
ABIVAX Société Anonyme Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
25I.F ImmuPharma plc
0.0265
-37.65%
SANNz.XC
0EVI.IL Innate Pharma S.A.
2.1375
-3.93%
VTRO
KAPA Kairos Pharma, Ltd.
1.1900
-1.65%
AFMD Affimed N.V.
1.0300
-0.96%
MBX MBX Biosciences, Inc.
9.60
-2.24%
ZBIO Zenas BioPharma, Inc.
7.01
+6.05%
BCAX Bicara Therapeutics Inc.
13.30
+7.61%
CSBR Champions Oncology, Inc.
10.28
+0.59%